US Stock MarketDetailed Quotes

ONCO Onconetix

Watchlist
  • 0.370
  • -0.097-20.77%
Trading Dec 13 11:54 ET
3.07MMarket Cap0.00P/E (TTM)

About Onconetix Company

Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company was founded in October 2018 and is headquartered in Cincinnati, OH.

Company Profile

SymbolONCO
Company NameOnconetix
Listing DateFeb 18, 2022
Founded2018
CEODr. Ralph Schiess
MarketNASDAQ
Employees23
Fiscal Year Ends12-31
Address201 East 5th Street,Suite 1900
CityCincinnati
ProvinceOhio
CountryUnited States of America
Zip Code45202
Phone1-513-620-4101

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ralph Schiess
  • Chief Science Officer and Interim Chief Executive Officer
  • --
  • Christian Bruhlmann
  • Chief Strategy Officer
  • --
  • Karina M. Fedasz
  • Interim Chief Financial Officer
  • --
  • James Sapirstein
  • Non-Executive Chairman of the Board and Lead Independent Director
  • 182.12K
  • Dr. Thomas Meier, PhD
  • Director
  • --
  • Dr. Ajit Singh, PhD.
  • Director
  • --
  • Timothy R. Ramdeen
  • Independent Director
  • 82.67K
  • Simon Tarsh
  • Independent Director
  • 112.62K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.